SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-055612
Filing Date
2024-05-08
Accepted
2024-05-08 16:05:25
Documents
13
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dvax-20240508.htm   iXBRL 8-K 39701
2 EX-99.1 dvax-ex99_1.htm EX-99.1 180399
3 GRAPHIC img191369596_0.jpg GRAPHIC 119568
  Complete submission text file 0000950170-24-055612.txt   508907

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dvax-20240508.xsd EX-101.SCH 23882
16 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20240508_htm.xml XML 4534
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 24925822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)